Observational Study of HIV+ Deceased Donor Transplant for HIV+ Recipients
Trial Summary
What is the purpose of this trial?
HIV-infected (HIV+) individuals who agree to accept and receive a solid organ transplant from an HIV+ deceased donor will be followed to determine the safety and efficacy of this practice. Some HIV+ individuals who receive a solid organ transplant from HIV-uninfected (HIV-) donors will also be followed.
Research Team
Christine Durand, MD
Principal Investigator
Johns Hopkins University
Eligibility Criteria
Inclusion Criteria
Treatment Details
Interventions
- HIV-infected deceased donor organ (Virus Therapy)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Johns Hopkins University
Lead Sponsor
Theodore DeWeese
Johns Hopkins University
Chief Executive Officer since 2023
MD from an unspecified institution
Allen Kachalia
Johns Hopkins University
Chief Medical Officer since 2023
MD from an unspecified institution
University of Maryland, Institute of Human Virology
Collaborator
Emory University
Collaborator
Dr. R. Donald Harvey
Emory University
Chief Medical Officer
MD from Emory University School of Medicine
Dr. George Painter
Emory University
Chief Executive Officer since 2013
PhD in Synthetic Organic Chemistry from Emory University
University of Maryland
Collaborator
Mr. Pearson
University of Maryland
Chief Executive Officer since 2019
B.S. in Business Administration from the University of Delaware, B.S. in Accounting from the University of Maryland University College, M.S. in Finance from Loyola University
Dr. Stuart McIntosh
University of Maryland
Chief Medical Officer
MD
Methodist Health System
Collaborator
James C. Scoggin, Jr.
Methodist Health System
Chief Executive Officer since 2019
BBA in Finance from Texas A&M University
Martin L. Koonsman
Methodist Health System
Chief Medical Officer
MD from Texas Tech University School of Medicine
Columbia University
Collaborator
Dr. Katrina Armstrong
Columbia University
Chief Executive Officer
MD from Johns Hopkins University, MS in Epidemiology from Harvard School of Public Health
Dr. Katrina Armstrong
Columbia University
Chief Medical Officer
MD from Harvard Medical School
Icahn School of Medicine at Mount Sinai
Collaborator
Dr. Brendan Carr
Icahn School of Medicine at Mount Sinai
Chief Executive Officer since 2024
MD, MA, MS
Dr. Vicki LoPachin
Icahn School of Medicine at Mount Sinai
Chief Medical Officer
MD, FACP, MBA
Weill Medical College of Cornell University
Collaborator
Dr. Robert Min
Weill Medical College of Cornell University
Chief Executive Officer since 2024
MD, MBA
Dr. Adam R. Stracher
Weill Medical College of Cornell University
Chief Medical Officer since 2024
MD
Georgetown University
Collaborator
Dr. Ivica Labuda
Georgetown University
Chief Executive Officer since 2022
PhD in Biochemistry and Molecular & Cellular Biology from Slovak Academy of Sciences, University of Graz, and Rutgers University
Dr. Richard Ascione
Georgetown University
Chief Medical Officer since 2023
MD from Georgetown University Medical School
University of Colorado, Denver
Collaborator
Aviva Abosch
University of Colorado, Denver
Chief Medical Officer since 2019
MD
Uday B. Kompella
University of Colorado, Denver
Chief Executive Officer since 2015
PhD in Pharmaceutical Sciences